2YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| PSB-SB-487 | 化合物PSB-SB-487 | 1399049-81-0 |
| RBC10 | RBC10 | 362503-73-9 |
| PD089828 | PD089828 | 179343-17-0 |
| GSK J1 | N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸 | 1373422-53-7 |
| SGC707 | N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 | 1687736-54-4 |
| ML-211 | 化合物ML-211 | 2205032-89-7 |
| Mycro3 | 944547-46-0 | 944547-46-0 |
| ARN272 | ARN272 | 488793-85-7 |
| CE3F4 | 143703-25-7 | 143703-25-7 |
| CRANAD-28 | CRANAD 28 | 1623747-97-6 |
| GSK5182 | CS-2620 | 877387-37-6 |
| GSK484 hydrochloride | CS-2265 | 1652591-81-5 |
| BPU-11 | BPU-11 | 909664-41-1 |
| RRX-001 | RRX-001 | 925206-65-1 |
| BMS-191011 | 3-(5-CHLORO-2-HYDROXYBENZYL)-5-(4-(TRIFLUOROMETHYL)PHENYL)-1,3,4-OXADIAZOL-2(3H)-ONE | 202821-81-6 |
| ISRIB | ISRIB | 548470-11-7 |
| PCO371 | PCO371 | 1613373-33-3 |
| (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile | GS-441524 | 1191237-69-0 |
| A 286982 | A 286982 | 280749-17-9 |
| K02288 | K02288 | 1431985-92-0 |
| BC-1215 | 化合物BC-1215 | 1507370-20-8 |
| NIBR-0213 | NIBR 0213 | 1233332-14-3 |
| Dafadine-A | CS-1223 | 1065506-69-5 |
| FPH2(BRD-9424) | FPH2 | 957485-64-2 |
| BC-1258 | N,N′-Bis-(4-thiazol-2-yl-benzyl)-ethane-1,2-diamine | 1507370-40-2 |
| KRAS G12D inhibitor 14 | 化合物 KRAS G12D INHIBITOR 14 | 2765254-39-3 |
| CYM50308 | CYM50308 | 1345858-76-5 |
| MRTX1133 | MRTX1133 | 2621928-55-8 |
| Galloflavin | 培黄素 | 568-80-9 |
| ML261 | 2-Chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-4-methyl-4H-thieno[3,2-b]pyrrole-5-carboxamide | 902523-58-4 |
| LDN-192960 dihydrochloride | 3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 | 184582-62-5 |
| WS3 | 重复 | 1421227-52-2 |
| ML335 | ML335 | 1069498-96-9 |
| JW 55 | JW-55 | 664993-53-7 |
| Boronic acid, B-[4-[[4-[(Z)-[3-[(4-fluorophenyl)Methyl]-2,4-dioxo-5-thiazolidinylidene]Methyl]phenoxy]Methyl]phenyl]- | CS-963 | 1312201-00-5 |
| WIKI4 | 化合物WIKI4 | 838818-26-1 |
| NSC-703786 | 4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯胺 | 260443-89-8 |
| CRT0066101 | 10MG | 956121-30-5 |
| ML179 | ML-179 | 1883548-87-5 |
| Kobe-0065 | N-(3-CHLORO-4-METHYLPHENYL)-2-(2,6-DINITRO-4-(TRIFLUOROMETHYL)PHENYL)HYDRAZINECARBOTHIOAMIDE | 436133-68-5 |
| AA92593 | 4-Methoxy-3-methylphenyl piperidin-1-yl sulphone, 2-Methyl-4-[(piperidin-1-yl)sulphonyl]anisole | 457961-34-1 |
| ML277 | ML-277 | 1401242-74-7 |
| Mps1-IN-3 | 1609584-72-6 | 1609584-72-6 |
| PCNA-I 1 | PCNA-I1 | 444930-42-1 |
| BMS453 | BMS453 | 166977-43-1 |
| Leukadherin-1 | 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸 | 344897-95-6 |
| YMU1 | Ethyl 4-(2-(4,6-dimethyl-3-oxoisothiazolo[5,4-b]pyridin-2(3H)-yl)acetyl)piperazine-1-carboxylate | 902589-96-2 |
| CRT5 | CRT5 | 1034297-58-9 |
| ML-180 | ML-180 | 863588-32-3 |
| ASN03576800 | ASN03576800 | 957513-35-8 |
| PU-H54 | 化合物PU-H54 | 1454619-13-6 |
| AT-56 | AT-56 | 162640-98-4 |
| PFK-015 | PFK-015 | 4382-63-2 |
| ML 254 | ML 254 | 1428630-86-7 |
| CRANAD-2 | (T-4)-[(1E,6E)-1,7-bis[4-(Dimethylamino)phenyl]-1,6-heptadiene-3,5-dionato-O3,O5]difluoroboron | 1193447-34-5 |
| VK-II-86 | 955371-84-3 | |
| PF 9601N | PF 9601N | 133845-63-3 |
| ML303 | ML303 | 1638211-04-7 |
| HA-155 | HA-155 | 1229652-22-5 |
| Nisoxetine hydrochloride | 盐酸尼索西汀 | 57754-86-6 |
| Fluxapyroxad | 氟苯吡菌胺 | 907204-31-3 |
| OS-3-106 | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-4-(thiazol-4-yl)benzamide | 1580000-17-4 |
| NSC 177223 | 4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide | 36707-00-3 |
| TH588 | TH588 HYDROCHLORIDE | 1609960-31-7 |
| B355252 | 4-Chloro-N-(naphthalen-1-ylmethyl)-5-(3-(piperazin-1-yl)phenoxy)thiophene-2-sulfonamide | 1261576-81-1 |
| Apcin | Apcin | 300815-04-7 |
| ML162 | ML162 | 1035072-16-2 |
| CH5183284(Debio-1347) | DEBIO-1347 | 1265229-25-1 |
| ML191 | ML-191 | 931695-79-3 |
| Oseltamivir | 奥司他韦 | 196618-13-0 |
| RO2959 hydrochloride | 化合物RO2959 HYDROCHLORIDE | 1219927-22-6 |
| LDN-211904 Oxalate | N-(2-氯苯基)-6-(4-哌啶基)-咪唑并[1,2-A]吡啶-3-甲酰胺草酸盐 | 1198408-78-4 |
| GSK-843 | GSK-843 | 1601496-05-2 |
| CGS-15943 | CGS 15943 | 104615-18-1 |
| ML298 | ML298 | 1426916-02-0 |
| Imidazenil | 米达西尼 | 151271-08-8 |
| SR8278 | SR8278;SR-8278;SR 8278 | 1254944-66-5 |
| SW155246 | 4-Chloro-N-(4-hydroxy-1-naphthalenyl)-3-nitro-benzenesulfonamide | 420092-79-1 |
| 4BP-TQS | 4BP-TQS | 360791-49-7 |
| TM5007 | 化合物TM5007 | 342595-05-5 |
| VK-II-36 | 化合物VK-II-43 | 955371-66-1 |
| ML336 | (E)-2-((1,4-二甲基哌嗪-2-亚基)氨基)-5-硝基-N-苯基苯甲酰胺 | 1613465-33-0 |
| JTE-013 | JTE-013 | 383150-41-2 |
| MCC950 | MCC950 | 210826-40-7 |
| Inauhzin | INAUHZIN | 309271-94-1 |
| MONNA | 2-(4-甲氧基萘-2-基氨基)-5-硝基苯甲酸 | 1572936-83-4 |
| GSK 2830371 | GSK 2830371 | 1404456-53-6 |
| FIT-039 | FIT-039 | 1113044-49-7 |
| ML-299 | ML-299 | 1426916-00-8 |
| CYM 2503 | (9H-芴-9 - 基)甲基((S)-1(((S)-6 - (叔丁氧基羰基)氨基-1 - ((4 - 甲基-2 - 氧代-1,2 - 二氢喹啉-7 - 基)氨基)-1 - 氧代己-2 - 基)氨基)-3 - 环己基-1 - 氧代丙-2 - 基)氨基甲酸叔丁酯 | 1308833-36-4 |
| Carbamic acid | ((S)-5-((2R,3S)-3-(N-羟基甲酰胺基)-2-异丁基六氨基)-2-氧代-6-(噻唑-2-基氨基)己基)氨基甲酸苄酯 | 866924-39-2 |
| VPC23019 | VPC 23019 | 449173-19-7 |
| Atglistatin | ATGLISTATIN | 1469924-27-3 |
| HS-1793 | 化合物HS-1793 | 927885-00-5 |
| 4'-Bromo-resveratrol | 5-[(E)-2-(4-溴苯基)乙烯基]间苯二酚 | 1224713-90-9 |
| YM26734 | YM 26734 | 144337-18-8 |
| TAE-1 | 2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide | 1414469-59-2 |
| ML240 | ML240 | 1346527-98-7 |
| GW779439X | 化合物GW779439X | 551919-98-3 |
| VUF11418 | N-[[(1R,5S)-6,6-二甲基双环[3.1.1]庚-2-烯-2-基]甲基]-2′-碘-N,N-二甲基[1,1′-联苯]-4-甲基碘化铵 | 1414376-85-4 |
联系方式
